inVENT-visIOn Study
- Conditions
- Interventions
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 42
- Registration Number
- NCT01444391
- Locations
- 🇺🇸
South Coast Ear, Nose, & Throat, Port Saint Lucie, Florida, United States
DuraSeal Exact Spine Sealant System Post-Approval Study
- Conditions
- Interventions
- First Posted Date
- 2011-08-05
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 924
- Registration Number
- NCT01410864
Healthy Volunteer Study
- Conditions
- Interventions
- First Posted Date
- 2011-05-03
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 106
- Registration Number
- NCT01346332
- Locations
- 🇺🇸
CEI Medical Group, East Palo Alto, California, United States
inVENT-In-Office Study
- Conditions
- Interventions
- First Posted Date
- 2011-03-29
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 85
- Registration Number
- NCT01324271
A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
- Conditions
- Interventions
- First Posted Date
- 2011-01-05
- Last Posted Date
- 2017-12-02
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 30
- Registration Number
- NCT01270633
- Locations
- 🇺🇸
Covenant Medical Center, Saginaw, Michigan, United States
🇵🇷Professional Hospital, Guaynabo, Puerto Rico
🇵🇷Wound and Ulcer Care Clinic of San Juan, San Juan, Puerto Rico
The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospective Randomized Double-Blinded Trial
- First Posted Date
- 2010-10-26
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Integra LifeSciences Corporation
- Registration Number
- NCT01228500
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers
- Conditions
- First Posted Date
- 2010-10-26
- Last Posted Date
- 2016-08-26
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 22
- Registration Number
- NCT01228526
- Locations
- 🇺🇸
Temple University School of Podiatric Medicine, Philadelphia, Pennsylvania, United States
🇺🇸New York College of Podiatric Medicine, New York, New York, United States
🇺🇸California School of Podiatric Medicine at Samuel Merritt University, Oakland, California, United States
Evaluation of the Tympanostomy Tube Delivery System
- Conditions
- Interventions
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 53
- Registration Number
- NCT01202578
- Locations
- 🇺🇸
South Coast ENT, Port Saint Lucie, Florida, United States
🇺🇸Advanced ENT and Allergy, Louisville, Kentucky, United States
🇺🇸Evergreen Sinus Center, Kirkland, Washington, United States
Optimization and Refinement of Technique in In-Office Sinus Dilation 2
- First Posted Date
- 2010-04-21
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 203
- Registration Number
- NCT01107379
A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
- Conditions
- Interventions
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2016-09-22
- Lead Sponsor
- Integra LifeSciences Corporation
- Target Recruit Count
- 545
- Registration Number
- NCT01060670
- Locations
- 🇺🇸
Advanced Foot Care and Clinical Research Center, Fresno, California, United States
🇺🇸Benchmark Research, Metarie, Louisiana, United States
🇺🇸Montana Medical Research, Missoula, Montana, United States